Johnson & Johnson to stop selling skin-lightening Neutrogena and Clean & Clear products

Published: 22-Jun-2020
Regulatory Skin Care

The personal care conglomerate has pulled its Neutrogena Fine Fairness and Clean & Clear Fairness products from its website

You need to be a subscriber to read this article.
Click here to find out more.

Johnson & Johnson (J&J) has decided to stop selling two of its skin-lightening products, after considering the implications of their product names and claims.

Neutrogena Fine Fairness, only available in Asia and the Middle

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Johnson and Johnson
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Skin Care

J&J recalls Clean & Clear Facial Cleansers in the US due to micro contamination

Read more
An FDA enforcement report notice states the company is voluntarily recalling at wholesale level 7,800 bottles of Clean & Clear’s Morning Burst Facial Cleanser

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    New eye creams are answering the top skin care concern for men Targeted eye treatments that banish dark circles and puffiness in an instant are trending, as brands see rising demand among men over 35
  2. Nivea helps push Beiersdorf sales to €4.9 billion in H1 Sun protection was pinpointed as a strong performance segment for the German giant's Nivea, Eucerin and Aquaphor brands
  3. Beiersdorf opens 'agile working' campus in Hamburg The 51,000sqm space includes a newly-built corporate headquarters
  4. Pure Beauty Global Awards 2024 finalists announced! The Pure Beauty editorial team has announced the best in the industry, now it is up to the expert judging panel to decide the winners
  5. Pamela Anderson enters skin care with Sonsie. Was make-up free 'rebellion' a PR stunt? The model and actress has acquired a stake in the minimalist beauty brand, which focuses on a ‘less is more’ approach to skin care

Upcoming event

CCE Safety Assessment Module 3, Toxicology 2

23 April 2024 | Virtual See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Skin Care

J&J recalls Clean & Clear Facial Cleansers in the US due to micro contamination

An FDA enforcement report notice states the company is voluntarily recalling at wholesale level 7,800 bottles of Clean & Clear’s Morning Burst Facial Cleanser
Skin Care

Neutrogena signs Olympic gold medalist Sydney McLaughlin-Levrone as ambassador

The US track star will represent the skin care brand alongside existing ambassadors Jenna Ortega and Chloe and Halle Bailey
Skin Care

J&J to hold 9.5% stake in consumer health spinoff Kenvue following share exchange

The multinational launched the exchange offer in July in a bid to take its hands off the Kenvue reins
Regulatory

Johnson & Johnson to appeal $19 million owed to California cancer patient

The talc cancer trial involving 24-year-old Emory Hernandez Valadez was the first faced by J&J since its bankruptcy filing
You need to be a subscriber to read this article.
Click here to find out more.
Colour Cosmetics

Metaverse Beauty Week day 4 review - madcap mushrooms and nonsensical buildings shadow over potential

The Cosmetics Business editorial team will be reviewing each day of Metaverse Beauty Week 2023, 12-17 June
Regulatory

Johnson & Johnson faces first new talc cancer trial since bankruptcy filing

Judge overseeing LTL Management’s Chapter 11 has allowed the trial to go ahead, as 24-year-old cancer patient Anthony Hernandez Valadez does not have long to live
You need to be a subscriber to read this article.
Click here to find out more.
Sustainability

Top 50 beauty brands 2023: Which is the world’s biggest brand?

L’Oréal has retained its status as the world’s most valuable beauty brand on Brand Finance’s league table, but did its value rise or dive in 2023?
Subscribe now